Brain Trust Accelerator Fund logo

Brain Trust Accelerator Fund

North America, California, United States, Burlingame

Description

Brain-Disease Research Investments

Investor Profile

Brain Trust Accelerator Fund has made 4 investments, with 1 in the past 12 months and 25% as lead.

Stage Focus

  • Series B (50%)
  • Series A (25%)
  • Seed (25%)

Country Focus

  • United States (100%)

Industry Focus

  • Health Care
  • Pharmaceutical
  • Neuroscience
  • Therapeutics
  • Apps
  • Artificial Intelligence (Ai)
  • Beauty
  • Biotechnology
  • Robotics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Brain Trust Accelerator Fund frequently co-invest with?

Rules-Based Medicine a Q Squared Solutions Company
North America, Texas, United States, Austin
Co-Investments: 1
Cleveland Clinic
North America, Ohio, United States, Cleveland
Co-Investments: 2
CRUINT
Europe, Pest, Hungary, Göd
Co-Investments: 1
Dolby Family Ventures
North America, California, United States, San Francisco
Co-Investments: 2
Life Science Angels
North America, California, United States, Sunnyvale
Co-Investments: 1
Foundation for a Better World
North America, Georgia, United States, Atlanta
Co-Investments: 1
Alzheimer's Drug Discovery Foundation
North America, New York, United States, New York
Co-Investments: 2
Prisma Ventures
North America, Illinois, United States, Bolingbrook
Co-Investments: 1

What are some of recent deals done by Brain Trust Accelerator Fund?

Neuro Therapia

Ohio, Illinois, United States

Neuro Therapia is developing new therapies for diseases with an underlying component of neuroinflammation.

Health CareNeurosciencePharmaceuticalTherapeutics
Series BAug 6, 2024
Amount Raised: $12,300,000
MyAvana

Atlanta, Georgia, United States

MyAvana provides hair care recommendation system for women of color.

AppsArtificial Intelligence (AI)BeautyHealth Care
SeedJan 11, 2024
Neuro Therapia

Ohio, Illinois, United States

Neuro Therapia is developing new therapies for diseases with an underlying component of neuroinflammation.

Health CareNeurosciencePharmaceuticalTherapeutics
Series ASep 22, 2020
Amount Raised: $8,800,000
Satoris

Redwood City, California, United States

Satoris develops tests for neurological diseases such as Alzheimer's, Parkinson's, Multiple Sclerosis, and Diabetic Neuropathy.

BiotechnologyHealth CarePharmaceuticalRobotics
Series BMar 25, 2008
Amount Raised: $5,200,000